Published in Clin Infect Dis on July 20, 2015
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures | NCT01898208
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis (2016) 2.32
Identification and Susceptibility Testing From Shortly Incubated Cultures Accelerate Blood Culture Diagnostics at No Cost. Clin Infect Dis (2015) 1.18
A Stewardship Approach To Optimize Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Gram-Negative Bacteria. J Clin Microbiol (2015) 0.84
Controversies in Antimicrobial Stewardship: Focus on New Rapid Diagnostic Technologies and Antimicrobials. Antibiotics (Basel) (2016) 0.84
Benefits of Adding a Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program. J Clin Microbiol (2016) 0.84
Implementation of Rapid Molecular Infectious Disease Diagnostics: The Role of Diagnostic and Antimicrobial Stewardship. J Clin Microbiol (2016) 0.82
The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma (2016) 0.80
Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs. Infect Dis Rep (2017) 0.79
The Confounding Role of Antimicrobial Stewardship Programs in Understanding the Impact of Technology on Patient Care. J Clin Microbiol (2016) 0.79
Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System. Clin Infect Dis (2016) 0.79
Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence (2016) 0.78
Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship. Clin Microbiol Rev (2016) 0.78
Antifungal stewardship considerations for adults and pediatrics. Virulence (2016) 0.76
A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa. PLoS One (2016) 0.76
Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Meningitis. Open Forum Infect Dis (2016) 0.75
Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know. Virulence (2017) 0.75
Editorial Commentary: Rapid Blood Culture Identification: The Value of a Randomized Trial. Clin Infect Dis (2015) 0.75
Individualized Approaches Are Needed for Optimized Blood Cultures. Clin Infect Dis (2016) 0.75
Reply to Idelevich and Beck. Clin Infect Dis (2015) 0.75
Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy. Antimicrob Resist Infect Control (2017) 0.75
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. Antimicrob Agents Chemother (2016) 0.75
Advances Afoot in Microbiology. J Clin Microbiol (2017) 0.75
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures. J Clin Microbiol (2015) 0.75
A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infect Dis Ther (2016) 0.75
ID Learning Unit-Diagnostics Update: Current Laboratory Methods for Rapid Pathogen Identification in Patients With Bloodstream Infections. Open Forum Infect Dis (2015) 0.75
Performance of microbial identification by MALDI-TOF MS and susceptibility testing by VITEK 2 from positive blood cultures after minimal incubation on solid media. Eur J Clin Microbiol Infect Dis (2017) 0.75
Real -time PCR for early microbiological diagnosis: is it time? Intensive Care Med (2017) 0.75
Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transplant (2017) 0.75
Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship. Eur J Clin Microbiol Infect Dis (2016) 0.75
Focus on adequate antimicrobial treatment and de-escalation in the ICU. Intensive Care Med (2016) 0.75
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med (2006) 23.62
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med (2014) 5.70
Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol (1999) 5.38
Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis (2013) 4.27
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med (2013) 4.26
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis (2010) 4.06
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis (2003) 3.20
Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med (2012) 2.62
Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother (2006) 2.57
Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis (2013) 2.53
Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother (2008) 2.32
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis (2012) 2.17
Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol (2006) 2.15
Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep (2014) 2.15
Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol (2013) 2.11
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect (2014) 1.94
Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis (2012) 1.83
Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol (2011) 1.51
Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci. J Clin Microbiol (2010) 1.37
Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. J Clin Microbiol (2008) 1.26
Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol (2010) 1.17
Hospital rules-based system: the next generation of medical informatics for patient safety. Am J Health Syst Pharm (2005) 1.03
Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing. J Infect (2012) 0.94
Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia. Clin Infect Dis (2015) 2.71
Genitourinary Procedures as Risk Factors for Prosthetic Hip or Knee Infection: A Hospital-Based Prospective Case-Control Study. Open Forum Infect Dis (2015) 0.75
Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci. Clin Infect Dis (2015) 0.75